================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                Date of Report (Date of earliest event reported):
                                 August 13, 2004

                               TRANSGENOMIC, INC.
             (Exact name of registrant as specified in its charter)

                Delaware                                 000-30975
           (State of Formation)                   (Commission File Number)

                                    911789357
                      (IRS Employer Identification Number)

           12325 Emmet Street
               Omaha, NE                                   68164
(Address of principal executive offices)                 (Zip Code)

                                 (402) 452-5400
              (Registrants' telephone number, including area code)

                                 Not applicable
          (Former name or former address, if changed since last report)

================================================================================



Item 5. Other Events and Regulation FD Disclosure.

      On August 12, 2004, the Company issued a press release announcing results
of operations and summary financial position for the quarter ended June 30,
2004. A copy of the press release is filed herewith as Exhibit 99.1 and is
incorporated herein by reference.

Item 7. Financial Statements and Exhibits.

      (c)   Exhibits

      99.1  Press Release, dated August 12, 2004, announcing the second quarter
            results of operations and summary financial position for the
            registrant's quarter ended June 30, 2004.

Item 12. Results of Operations and Financial Condition.

      On August 12, 2004, Transgenomic, Inc. (the "Company") issued a press
release announcing results of operations and summary financial position for the
quarter ended June 30, 2004. The Company is attaching the press release as
Exhibit 99.1 to this Current Report on Form 8-K.



                                    SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                     TRANSGENOMIC, INC.

                                     By   /s/ Mitchell L. Murphy
                                          --------------------------------------
                                          Mitchell L. Murphy, Vice President,
                                          Secretary & Treasurer

August 13, 2004